Faculty bio page2
No image

David G. Brust, MDAssistant Professor
Associate Medical Director of Blood Bank and Transfusion Medicine Services

Department of Pathology
Phone: (409) 747-0763
Email: dabrust@utmb.edu

David G. Brust, MD

Cellular therapies including chimeric antigen receptor T cell immunotherapy and oncolytic viruses utilizing next generation CRISPR/Cas9 gene editing technologies.
National Institutes of Health Fellowship Transfusion Medicine 2019
Wake Forest University Residency Anatomic and Clinical Pathology 2017
Louisiana State University Residency Emergency Medicine 2006
Eastern Virginia Medical School Medical Doctorate Doctor of Medicine 2002
University of Richmond Bachelor of Arts Biology/PreMed major, chemistry minor 1995

Speaker, National Institutes of Health, 37th Annual Immunohematology and Blood Transfusion Symposium “A Challenging Case of an Exceptionally Rare Antibody”

2018

Speaker, American Association of Blood Banks Latin Section for Cellular Therapy “Next Generation Chimeric Antigen Receptor T-Cell Immunotherapy”

2018

Speaker, 40th Annual Conference of the American Society for Apheresis, Plenary Session Presentation “The Effect of Hydroxyethyl Starch on Renal Function in Long Term Granulocyte Donors”

2019

Speaker, 40th Annual Conference of the American Society for Apheresis, Poster Presentation “The Effect of Repeated Dexamethasone Administration on Bone Mineral Density in Long Term Granulocyte Donors”

2019

American Association of Blood Banks 2019 - Present
American Society for Therapeutic Apheresis 2019 - Present
American Board of Pathology 2017 – Present
North Carolina Society for Pathologists 2016 – Present
American Society for Clinical Pathology 2013 - Present
Brust D, Wu K, West K, Yau Y, Scinto T, Sun J, Natanson C, Klein H, Cantilena C. “The effect of hydroxyethyl starch on renal function in long term granulocyte donors.” In process.

Brust D, Wu K, Scinto T, Yau Y, Reynolds J, West K, Cantilena C. “The effect of repeated dexamethasone administration on bone mineral density in long term granulocyte donors.”  In process.

Brust D, Feden J, Farnsworth J, Amir C, Broaddus WC, Valerie K. “Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.” Cancer Gene Ther. 2000 May;7(5):778-88. DOI 10.1038/sj.cgt.7700168 PubMed PMID: 10830725.

Valerie K, Brust D, Farnsworth J, Amir C, Taher MM, Hershey C, Feden J. “Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.” Cancer Gene Ther. 2000 Jun;7(6):879-84. DOI 10.1038/sj.cgt.7700185 PubMed PMID: 10880018.